Navigation Links
RA Drugs Not Implicated In Cancer

Rheumatoid arthritis (RA) patients have an increased risk of developing lymphoma and leukemia. The autoimmune, inflammatory disease that causes a lot of joint pain does have the risk of cancer. //Researchers speculate that antirheumatic drugs (DMARDs) – including tumor necrosis factor alpha (TNFá) antagonists, a type of biologic DMARD may play a role in this.

TNF blockers, which work by attaching to and impeding chemical messengers behind inflammation, have had a significant impact on the treatment of RA. They have also been linked to lymphoma among users. In fact, reports of lymphoma prompted the Food and Drug Administration to mandate adding a cancer risk warning to the labels of three TNF blockers: etanercept (Enbrel), infliximab (Remicade), and adalimumab (Humira).

Motivated by persistent concerns and inconclusive studies, researchers at Harvard Medical School's Brigham and Women's Hospital set out to investigate the association between treatment with TNF blockers and occurrence of cancer in a large sample of patients with RA. Their results, featured in the September 2006 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/
journal/arthritis), indicate that biologic DMARD therapy poses no greater risk for cancer than therapy with a standard prescription DMARD, methotrexate (MTX).

The researchers focused on 7,830 RA patients, age 65 and older, drawn from healthcare databases in New Jersey, Pennsylvania, and British Columbia, Canada. Subjects included 1,152 biologic DMARD users and 7,306 MTX users. Of those treated with a biologic DMARD, 64 percent had used etanercept, 33 percent had used infliximab, and the remaining 2 percent had used anakinra (Kineret). 55 percent had previously used MTX and 39 percent were receiving MTX when they began anti-TFN therapy.

Based on medical utilization information, the researchers measured every subject's general health and RA-related characteristics during the 6-mo
'"/>




Page: 1 2

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drugs Not Implicated Cancer

(Date:12/2/2009)...CH, Va., Dec. 2 By now, most peopl...igarettes continue to grow in popularity. And, the...the PremiumEcigarette - the new single piece Premi... amazingly low price of $14.99. ,, "This new pr...garette at a very low price, before making a bigge...
(Date:12/2/2009)...NEW YORK, Dec. 2 Care Support of ...rdination, Advanced Illness Coordinated Care (AIC...the last years of life as well as improve the qual...s without increasing mortality. These are the prin...an Journal of Managed Care (November 2009). ,,...
(Date:12/2/2009)...ni loves sports. An avid tennis player and golfer,...e agent became increasingly frustrated over time a...rative eye disorder. Unable to return the tennis b...e prospect of a corneal transplant to restore his ...Balboni discovered an alternative treatment. He re...
(Date:12/2/2009)... AB First Aid has been a top name in the medical s...quality products, professional staff, and a keen u...B First Aid has established itself as a provider o...d as a first aid supplies distributor. The disting... enter into its next phase with the redesign and l...
(Date:12/2/2009)... 2 The American Health ...ctors today announced Alan F. Dowling, PhD, will b...alth information management (HIM) leader. Dr. Dow...ludes academia, systems management, strategic expe... executive leadership. He is scheduled to take of...
Breaking Medicine News(10 mins):Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2
...he same diet make some of us gain more weight than...olecule called BSX, as scientists from the Europea... Institute for Nutrition [DIFE], Potsdam, and the ...ood intake. Mice lacking the molecule show less sp...
...sai Yen-ping is a feminist who does not advocate m...anese women . Rather, the legendary skincare ...t their self-esteem and financial independence in ...970s, has helped improve the lives of tens of thou...
...ith nearly 30,000 people in south and central dist...r, an infection spread by the Aedes mosquito , the...overnment. Reports from Pathanamthitta, Kot...party meeting on Friday to discuss this issue and ...
...OHAN (Multi Organ Harvesting Aid Network) Foundati...Donor Families at Raj Bhavan on 7th of June 2007. ...hat one human being can give to another. Since 199...er declaration of brain death by specialists. MOHA...
...esearchers at the Translational Genomics Research ...nos Science Laboratory and their collaborative par...ies an individuals risk for Alzheimer's disease wh...ople. The progressive neurological disorder afflic...
...esearchers at the Abramson Family Cancer Research ...ound that deleting a gene important in embryo deve... cell reservoirs in adult mice. This gene, ATR, is...rders in humans. The reason these mice age...
Other Medicine News:Health News:Molecular Basis of Obesity-Revealing the Unknown Facts 2Health News:Taiwan Skincare Empire Built on 'Natural Beauty' 2Health News:Taiwan Skincare Empire Built on 'Natural Beauty' 3Health News:Honoring of Organ Donor Families at Raj Bhavan in Chennai 2Health News:GAB2-A New Alzheimers Gene Identified 2Health News:GAB2-A New Alzheimers Gene Identified 3Health News:Loss of Stem Cells Correlates With Premature Aging 2
(Date:12/2/2009)...EW YORK, Dec. 2 Keryx Bi...unced that the U.S. Food and Drug Administration (...01 (perifosine), the Company,s novel, potentially ...ts the phosphoinositide 3-kinase (PI3K)/Akt pathwa...le myeloma. ,, The Fast Track program of the ...
(Date:12/2/2009)...ISO VIEJO, Calif., Dec. 2 /PRNewswire-FirstCall/ -...ology and services resource for pathologists, onco...ounced a Chief Financial Officer transition plan t...R. Rodriguez to become its Senior Vice President a...ymond J. Land, age 64, the current Senior Vice Pre...
(Date:12/1/2009)..., MONTREAL and DUSSELDORF, Germany, Dec. 1 /PRN...facturer of specialized graphics solutions, is ple...shipping the Matrox Xenia(TM) Series display cont...ography solutions using Fujifilm Synapse. ,, F...r based radiography, offering the world,s first in...
Breaking Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Clarient Announces CFO Transition Plan 2Clarient Announces CFO Transition Plan 3Clarient Announces CFO Transition Plan 4FUJIFILM Europe Teams Synapse with Matrox Xenia 2FUJIFILM Europe Teams Synapse with Matrox Xenia 3Morphotek 28R 29 Inc and Cancer Innovations Inc Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies 13039 1Morphotek 28R 29 Inc and Cancer Innovations Inc Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies 13039 2Morphotek 28R 29 Inc and Cancer Innovations Inc Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies 13039 3Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 1Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 2Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 3Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 4Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 5Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 6Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 7Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 8Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 9Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 10Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 11Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 12Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 13Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 14Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 15Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 16Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 17Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 18Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 19Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 20Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 21Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 1Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 2Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 3
...est Pipettor , , The Shortyavailable with both Im...ow our face-to-face relationship with the scientif...ucts that make pipetting easier and more effective...nnel pipettors., Gets you closer to the working ...
BioPette E Electronic Pipettor, 10-200l
Finnpipette BioControl Single Channel, 40-200ul
...ctronic Pipette is ideal for all liquid handling a...display, ergonomically-placed operating buttons, a..., dispensing, reverse pipetting and diluting make ...mple functions of a manual pipette without any adv...
Medicine Products: